Where’s Lilly’s Alzheimer’s approval?
Eli Lilly’s treatment for Alzheimer’s was up for a sure-thing FDA approval in Q4. Then that timeline shifted to Q1 of 2024. Now we’re two-thirds into that quarter with no…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello, everyone. Damian here. I’d like to heartily recommend you check out Part 1 of The War on Recovery, a yearlong STAT investigation into how the U.S. denies lifesaving medications to people with opioid addiction.
What's Your Reaction?
